These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 18190887

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.
    Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J.
    Science; 2001 Nov 16; 294(5546):1540-3. PubMed ID: 11711679
    [Abstract] [Full Text] [Related]

  • 3. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment.
    Vera-Lastra O, Mendez C, Jara LJ, Cisneros M, Medina G, Ariza R, Espinoza LR.
    J Rheumatol; 2003 Oct 16; 30(10):2140-6. PubMed ID: 14528507
    [Abstract] [Full Text] [Related]

  • 4. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays.
    Cárdenas-Mondragón G, Ulloa-Aguirre A, Isordia-Salas I, Goffin V, Leaños-Miranda A.
    J Rheumatol; 2007 Jul 16; 34(7):1514-21. PubMed ID: 17516622
    [Abstract] [Full Text] [Related]

  • 5. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity.
    Leaños-Miranda A, Cárdenas-Mondragón G.
    Rheumatology (Oxford); 2006 Jan 16; 45(1):97-101. PubMed ID: 16249247
    [Abstract] [Full Text] [Related]

  • 6. Phenotypic analysis of IL-10-treated, monocyte-derived dendritic cells in patients with systemic lupus erythematosus.
    Figueroa-Vega N, Galindo-Rodríguez G, Bajaña S, Portales-Pérez D, Abud-Mendoza C, Sánchez-Torres C, González-Amaro R.
    Scand J Immunol; 2006 Dec 16; 64(6):668-76. PubMed ID: 17083624
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity.
    Leaños-Miranda A, Pascoe-Lira D, Chávez-Rueda KA, Blanco-Favela F.
    J Rheumatol; 2001 Jul 16; 28(7):1546-53. PubMed ID: 11469460
    [Abstract] [Full Text] [Related]

  • 12. Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Duffau P, Seneschal J, Nicco C, Richez C, Lazaro E, Douchet I, Bordes C, Viallard JF, Goulvestre C, Pellegrin JL, Weil B, Moreau JF, Batteux F, Blanco P.
    Sci Transl Med; 2010 Sep 01; 2(47):47ra63. PubMed ID: 20811042
    [Abstract] [Full Text] [Related]

  • 13. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.
    Lövgren T, Eloranta ML, Båve U, Alm GV, Rönnblom L.
    Arthritis Rheum; 2004 Jun 01; 50(6):1861-72. PubMed ID: 15188363
    [Abstract] [Full Text] [Related]

  • 14. Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus.
    Decker P, Kötter I, Klein R, Berner B, Rammensee HG.
    Rheumatology (Oxford); 2006 Sep 01; 45(9):1087-95. PubMed ID: 16527880
    [Abstract] [Full Text] [Related]

  • 15. [A review of the effects of prolactin hormone and cytokine on the development and pathogenesis of autoimmune diseases].
    Fojtíková M, Cerná M, Pavelka K.
    Vnitr Lek; 2010 May 01; 56(5):402-13. PubMed ID: 20578590
    [Abstract] [Full Text] [Related]

  • 16. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells.
    Cederblad B, Blomberg S, Vallin H, Perers A, Alm GV, Rönnblom L.
    J Autoimmun; 1998 Oct 01; 11(5):465-70. PubMed ID: 9802930
    [Abstract] [Full Text] [Related]

  • 17. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
    Leaños-Miranda A, Chávez-Rueda KA, Blanco-Favela F.
    Arthritis Rheum; 2001 Apr 01; 44(4):866-75. PubMed ID: 11315926
    [Abstract] [Full Text] [Related]

  • 18. Altered dendritic cells with tolerizing phenotype in patients with systemic lupus erythematosus.
    Berkun Y, Verbovetski I, Ben-Ami A, Paran D, Caspi D, Krispin A, Trahtemberg U, Gill O, Naparstek Y, Mevorach D.
    Eur J Immunol; 2008 Oct 01; 38(10):2896-904. PubMed ID: 18958888
    [Abstract] [Full Text] [Related]

  • 19. Prolactin in human systemic lupus erythematosus.
    Jara LJ, Vera-Lastra O, Miranda JM, Alcala M, Alvarez-Nemegyei J.
    Lupus; 2001 Oct 01; 10(10):748-56. PubMed ID: 11721702
    [Abstract] [Full Text] [Related]

  • 20. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis.
    Lood C, Gullstrand B, Truedsson L, Olin AI, Alm GV, Rönnblom L, Sturfelt G, Eloranta ML, Bengtsson AA.
    Arthritis Rheum; 2009 Oct 01; 60(10):3081-90. PubMed ID: 19790049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.